カリフォルニア州における血友病の臨床試験
カリフォルニア州内の拠点で、血友病に関する14件の研究が参加者を募集しています。
カリフォルニア州内の都市
公式研究テキスト（英語）
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- The Regents of the University of California||UC Davis Health, Rancho Cordova
- UC Davis Health, Sacramento
- UC Davis Ambulatory Care Clinic, Sacramento
- 他3件
被験者募集中第3相
18歳以上 · 男性 · 2026/10/02更新 · NCT05568719A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
- Children's Hospital Los Angeles- Site Number : 8400005, Los Angeles
被験者募集中第4相
12歳以上 · 男性 · 2026/09/23更新 · NCT06145373A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
- UC Davis Cancer Center, Sacramento
被験者募集中第1/2相
2歳〜59歳 · 男性 · 2026/09/11更新 · NCT05987449A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
- Center for Inherited Blood Disorders, Orange
- University of California San Francisco, San Francisco
- Kaiser Permanente, Vallejo
被験者募集中第1/2相
18歳以上 · 男性 · 2026/09/11更新 · NCT07226206A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Center for Inherited Blood Disorders, Orange
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/04更新 · NCT07416604Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Lucile Packard Children's Hospital, Palo Alto
被験者募集中観察研究健康なボランティア歓迎
0歳〜20歳 · 全性別 · 2026/08/21更新 · NCT04278404ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Orthopaedic Institute for Children HTC, Los Angeles
- Childrens Hospital Los Angeles, Los Angeles
- UCSF Benioff Children's Hospital Oakland, Oakland
- 他5件
被験者募集中観察研究
全年齢 · 全性別 · 2026/08/17更新 · NCT04398628A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
- The Luskin Orthopaedic Institute for Children- Site Number : 8400013, Los Angeles
- The Center for Inherited Blood Disorders- Site Number : 8400009, Orange
被験者募集中第3相
1歳〜11歳 · 男性 · 2026/08/17更新 · NCT07285460Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Stanford University, Palo Alto
- Rady Children's Hospital, San Diego
被験者募集中観察研究
6歳〜19歳 · 全性別 · 2026/07/02更新 · NCT05022459A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- Children's Hospital Los Angeles, Los Angeles
被験者募集中第1相健康なボランティア歓迎
18歳〜60歳 · 全性別 · 2026/07/02更新 · NCT06349473A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
- Orthopaedic Institute for Children/Orthopaedic Hemophilia Treatment Center, Los Angeles
被験者募集中第1相
12歳〜74歳 · 男性 · 2026/06/03更新 · NCT06703606Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD), Orange
- Stanford University: Stanford Children's Health, Redwood City
被験者募集中第1相
0歳〜90歳 · 全性別 · 2026/04/03更新 · NCT05500807SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Orthopaedic Institute for Children, Los Angeles
- University of California at Davis UC Davis Hemostasis and Thrombosis Center, Sacramento
被験者募集中第4相
12歳〜100歳 · 全性別 · 2026/01/12更新 · NCT04647227Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
- Orthopedic Institute for Children- Site Number : 8400009, Los Angeles
被験者募集中第4相
12歳以上 · 全性別 · 2025/11/18更新 · NCT06941870ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。